Cholangiocyte biology in primary sclerosing cholangitis and other cholangiopathies: pathogenesis, clinical insights, and experimental tools
Physiological Reviews · 01.07.2026 · 106 (3) · 1913-1954
DOI: 10.1152/physrev.00022.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiological Reviews, erschienen am 01.07.2026. Verfasst von Nidhi Jalan-Sakrikar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Bile Ducts, Epithelial Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 412 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Cholangiocytes are specialized epithelial cells that line the intrahepatic and extrahepatic biliary tree and play a critical role in bile modification, liver homeostasis, and response to injury. Cholangiocytes exhibit notable heterogeneity and plasticity, and their dysfunction is central to a spectrum of diseases targeting the bile ducts, collectively called cholangiopathies. These disorders include genetic, infectious, immune-mediated, and malignant diseases, with primary sclerosing cholangitis (PSC) representing one of the most complex and enigmatic of these disorders. PSC is a progressive, fibro-inflammatory disease of the bile ducts that is closely linked to inflammatory bowel disease, carries a heightened risk of cancer, and lacks any approved therapies. This review explores the biology of cholangiocytes, including their development, functional plasticity, and roles in secretion, absorption, and cellular signaling. We provide a detailed examination of cholangiopathies, particularly PSC, a complex cholangiopathy characterized by a paradoxical state of cholangiocyte senescence and hyperproliferation. We describe how immune cell dysfunction, the gut microbiome, genetic predispositions, and environmental factors converge to mediate PSC pathogenesis. We revisit the foundational technologies that empowered early discoveries and shaped the field as we know it today. We also explore how newer techniques such as organoid cultures, single-cell transcriptomics, epigenomics, and spatialomics have transformed our modern understanding of biliary pathophysiology. Finally, we provide an overview of existing rodent models of cholangiopathies and discuss their relevance to human disease. PSC remains therapeutically unaddressed, and thus ongoing multidisciplinary efforts are essential to developing targeted interventions. This review serves as a comprehensive resource for researchers and clinicians navigating the rapidly evolving landscape of cholangiocyte-centered liver disease research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States.
- Gastroenterology Research Unit, Mayo Clinic, Rochester, Minnesota, United States.
- Mayo Clinic Center for Cell Signaling in Gastroenterology, Mayo College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, United States.
- Division of Gastroenterology and Hepatology, University of Missouri School of Medicine, Columbia, Missouri, United States.
- UMass Chan Medical School, Worcester, Massachusetts, United States.
- Department of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands.
ORCID-Profile: Nidhi Jalan-Sakrikar, Nicholas F LaRusso
Förderung
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIDDK NIH HHS
- NCATS NIH HHS
- MC | Center for Clinical and Translational Science, Mayo Clinic (CCaTS)
- American Association for the Study of Liver Diseases (AASLD)
- PSC Partners Seeking a Cure (PSC)
- HHS | NIH | National Center for Advancing Translational Sciences
Zitieren
APA
Jalan-Sakrikar, N., Anwar, A. A., Ali, A., Nasser-Ghodsi, N., Felzen, A., Huebert, R. C., LaRusso, N. F., & O'Hara, S. P. (2026). Cholangiocyte biology in primary sclerosing cholangitis and other cholangiopathies: pathogenesis, clinical insights, and experimental tools. Physiological Reviews, 106(3), 1913-1954. https://doi.org/10.1152/physrev.00022.2025
Vancouver
Jalan-Sakrikar N, Anwar AA, Ali A, Nasser-Ghodsi N, Felzen A, Huebert RC, et al. Cholangiocyte biology in primary sclerosing cholangitis and other cholangiopathies: pathogenesis, clinical insights, and experimental tools. Physiological Reviews. 2026;106(3):1913-1954. doi:10.1152/physrev.00022.2025
BibTeX
@article{JalanSakrikar2026,
author = {Jalan-Sakrikar, Nidhi and Anwar, Abid A and Ali, Ahmad and Nasser-Ghodsi, Navine and Felzen, Antonia and Huebert, Robert C and LaRusso, Nicholas F and O'Hara, Steven P},
title = {Cholangiocyte biology in primary sclerosing cholangitis and other cholangiopathies: pathogenesis, clinical insights, and experimental tools},
journal = {Physiological Reviews},
year = {2026},
volume = {106},
number = {3},
pages = {1913--1954},
doi = {10.1152/physrev.00022.2025}
}
EUVIMED